Login

Switch On Your HIV Smarts.

In a class of its own, “uniquely potent” HIV capsid inhibitor thwarts HIV replication

In a class of its own, “uniquely potent” HIV capsid inhibitor thwarts HIV replication

March 14, 2017, by

Promising research about a new type of HIV drug called GS-CA1, the first capsid inhibitor to enter clinical trials, was shared at CROI 2017. Read More

New antibody therapy “profoundly” successful at reducing inflammation from HIV

New antibody therapy “profoundly” successful at reducing inflammation from HIV

March 8, 2017, by

With just one dose, canakinumab reduced markers of inflammation and improved arterial function in people living with HIV. Read More

With healthcare for millions at stake, Republicans unveil flawed, cost-cutting Affordable Care Act replacement

With healthcare for millions at stake, Republicans unveil flawed, cost-cutting Affordable Care Act replacement

March 7, 2017, by

Policy experts explain what the effects of the proposed replacement bill might be for people living with HIV. Read More

PrEP study now enrolling at Strut in San Francisco

PrEP study now enrolling at Strut in San Francisco

March 7, 2017, by

San Francisco AIDS Foundation is enrolling people into a study testing an investigational new drug for PrEP. Find out what the study’s about, and how to get involved. Read More

Antibody therapies effective at preventing HIV from invading CD4 cells

Antibody therapies effective at preventing HIV from invading CD4 cells

March 2, 2017, by

Research on two new long-acting antibody therapies demonstrates success at protecting CD4 cells and suppressing viral loads in people living with HIV. Read More